Joshua Silverman
Amministratore Delegato presso Aromyx Corp.
Profilo
Joshua Silverman is the founder of Versartis, Inc. (founded in 2008), Calysta, Inc. (founded in 2011), and Windfall Bio (founded in 2023).
At Calysta, he held the title of Chief Technology Officer from 2011 to 2016.
At Windfall Bio, he currently holds the title of Chief Executive Officer & Director.
He is also currently the Chief Executive Officer at Aromyx Corp.
Dr. Silverman previously worked as a Director-Process Development at Amgen, Inc., a Scientist at Maxygen, Inc., and a Vice President-Product Development at Amunix, Inc. Dr. Silverman received a doctorate degree from Stanford University and an undergraduate degree from The University of California, San Francisco.
Posizioni attive di Joshua Silverman
Società | Posizione | Inizio |
---|---|---|
Aromyx Corp.
Aromyx Corp. Packaged SoftwareTechnology Services Aromyx Corp. engages in the using of biological receptors from the human nose to create digital representations of smell sensory data for multiple application. Its products include EssenceChip, EssenceCapture, EssenceAnalytics, and EssenceCloud. The company was founded by Chris Hanson and is headquartered in Palo Alto, CA. | Amministratore Delegato | - |
Windfall Bio
Windfall Bio Chemicals: AgriculturalProcess Industries Windfall Bio is a technology company based in the US that specializes in developing nature-based solutions. The American company has created a methane-to-value solution that utilizes methane-eating microbes to convert harmful emissions into organic soil nutrients. This technology can be applied in various industries such as oil and gas, landfills, and waste management, as well as in agricultural settings. Windfall Bio's solution aims to reduce the carbon footprint of the food system and increase profits for farmers without increasing costs for consumers. | Fondatore | 01/01/2023 |
Precedenti posizioni note di Joshua Silverman
Società | Posizione | Fine |
---|---|---|
Amunix, Inc.
Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Corporate Officer/Principal | - |
AMGEN INC. | Corporate Officer/Principal | - |
Calysta, Inc.
Calysta, Inc. Agricultural Commodities/MillingProcess Industries Calysta, Inc. provides sustainable industrial products for food and energy security. The firm develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. It’s technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels. The company was founded in 2012 by Joshua Silverman and Alan Shaw and is headquartered in Menlo Park, CA. | Fondatore | - |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | - |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Fondatore | - |
Formazione di Joshua Silverman
Stanford University | Doctorate Degree |
The University of California, San Francisco | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
AMGEN INC. | Health Technology |
Aziende private | 6 |
---|---|
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Amunix, Inc.
Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Health Technology |
Calysta, Inc.
Calysta, Inc. Agricultural Commodities/MillingProcess Industries Calysta, Inc. provides sustainable industrial products for food and energy security. The firm develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. It’s technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels. The company was founded in 2012 by Joshua Silverman and Alan Shaw and is headquartered in Menlo Park, CA. | Process Industries |
Aromyx Corp.
Aromyx Corp. Packaged SoftwareTechnology Services Aromyx Corp. engages in the using of biological receptors from the human nose to create digital representations of smell sensory data for multiple application. Its products include EssenceChip, EssenceCapture, EssenceAnalytics, and EssenceCloud. The company was founded by Chris Hanson and is headquartered in Palo Alto, CA. | Technology Services |
Windfall Bio
Windfall Bio Chemicals: AgriculturalProcess Industries Windfall Bio is a technology company based in the US that specializes in developing nature-based solutions. The American company has created a methane-to-value solution that utilizes methane-eating microbes to convert harmful emissions into organic soil nutrients. This technology can be applied in various industries such as oil and gas, landfills, and waste management, as well as in agricultural settings. Windfall Bio's solution aims to reduce the carbon footprint of the food system and increase profits for farmers without increasing costs for consumers. | Process Industries |
- Borsa valori
- Insiders
- Joshua Silverman